Start your day with health and medicine insights by subscribing to STAT’s free newsletter, Morning Rounds. Sign up here.
In yesterday’s edition of Your Local Epidemiologist, Katelyn Jetelina stated: “If you’re feeling unwell, it’s likely due to either the common cold or Covid-19.” After trying both an expired and a new test with negative results, I can confidently say this is my first significant cold of the season. A big thank you to Rose for swapping newsletter days with me this week. Now, let’s dive into today’s health news—there’s a lot to cover.
The CDC Faces Challenges: Key Insights from the Recent Senate Hearing
During a recent tense Senate health committee hearing, two former leaders of the CDC provided testimony regarding perceived political interference in the agency’s decision-making process.
The hearing shed light on a CMS that has not only suffered job losses but has also cultivated an environment of fear among its staff, according to STAT’s Liz Cooney. During the proceedings, former CDC Chief Medical Officer Debra Houry clarified a grave misstatement regarding threats to the agency, revealing that 500 bullets were fired at the CDC’s Atlanta headquarters last month: “Each bullet was directed toward an individual, and every one of my colleagues was deeply traumatized,” she noted. For the latest on the CDC’s challenges, take a closer look at Liz’s report on the current state of the agency.
Senator Bill Cassidy (R-La.) initiated the hearing, calling for transparency around the circumstances of CDC Director Susan Monarez’s recent ouster. Monarez discussed potential shifts in health policies under Secretary Robert F. Kennedy Jr., who intends to revise the childhood vaccination schedule this month. Despite any adjustments to vaccine recommendations, insurers have committed to continuing coverage for existing vaccines.
The political dynamics at play were elaborated upon by STAT’s Daniel Payne and Isabella Cueto, who summarized three key takeaways from the hearing.
Former Fox News Journalist Justifies Her Qualifications for Drug Czar Role
Meanwhile on Capitol Hill, a confirmation hearing took place for the nation’s top drug policy position, overseeing the White House Office of National Drug Control Policy.
Nominee and former Fox News journalist Sara Carter defended her qualifications in response to skeptical questioning from Democratic senators. While Carter has received numerous journalism awards in her early career, her pivot to right-wing media focused on drug trafficking and border issues has raised eyebrows, particularly because she lacks any formal experience in government, law enforcement, medicine, or public health. An in-depth discussion on her qualifications can be found in STAT’s coverage by Lev Facher here.
ACIP Meeting: A Potential Turning Point for Childhood Vaccination Policies
Today marks a significant government meeting, as the Advisory Committee on Immunization Practices (ACIP) convenes in Atlanta to discuss proposed changes to the childhood vaccination schedule. As foreseen by Monarez, there’s concern among experts that ACIP may recommend limiting the availability of widely used vaccines.
During their last meeting, some ACIP members exhibited skepticism towards vaccines, but did not endorse major alterations to the existing schedule. However, with Monarez removed and five new members now on the committee, many experts believe the group could push for more radical changes. Jose Romero, a former ACIP chair, signaled potential risks earlier this month, remarking on the “freedom” new members might feel to implement aggressive changes. For insights into what experts anticipate, read more here.
The agenda includes discussions on Covid-19 vaccines as well as other immunization strategies against diseases such as hepatitis B. Just last week, STAT’s Eric Boodman provided insights into the evolution of hepatitis B universal infant vaccination and its vital significance—read more here.
NIH’s Stance on Foreign Subawards: A New Chapter for International Collaboration
Typically, American researchers have been enabled to allocate a portion of their NIH funding toward international partnerships via foreign subawards. This practice has been crucial for expanding global networks focused on critical studies, such as childhood cancer and diseases more prevalent in other countries like malaria and tuberculosis. Their use has been put under scrutiny since the COVD-19 pandemic.
Amid concerns regarding transparency in managing foreign subawards, the NIH announced earlier this spring that these would no longer be permitted. This decision was framed by NIH leaders as a temporary measure while transitioning to a new framework better equipped for tracking funding allocation. Recently, the NIH quietly released preliminary details about this new framework; however, key elements such as how researchers will submit proposals remain unclear.
In an interview with STAT’s Megan Molteni, Jon Lorsch, the acting deputy director for extramural research at NIH, along with NIH grants officials and independent experts, discussed the potential implications for international research collaborations. To read more about this developing situation, click here.
Public Opinion on Involuntary Commitments: A Closer Look
This past July, President Trump signed an executive order aimed at expanding involuntary commitments to combat homelessness. However, what do Americans truly think about forcing individuals to receive medication or hospitalization against their will?
A recent survey analysis published in JAMA Network Open indicates a considerable portion of respondents from various political backgrounds supports such measures. Statistics reveal that 40% endorse policies facilitating the forceful administration of medication, while 42% favor mandatory long-term hospitalizations, and 45% approve short-term involuntary commitments. Conversely, 72% advocate for the expansion of community services, and 65% support increased access to peer-led initiatives.
“The significant backing for noncoercive policies presents an opportunity for bipartisan collaboration,” the study’s authors wrote in a related commentary.
Geier’s Laptop: An Uncertain Fate
Amid all these proceedings, one notably scheduled meeting was abruptly cancelled. A conference between Kennedy, anti-vaccine advocate David Geier, and leaders from a significant database monitoring vaccine safety was pulled from the agenda. This meeting was likely intended to explore potential correlations between autism and the national childhood vaccination initiative.
Geier and his father previously had access to this data around twenty years ago but lost it when it was revealed they were pursuing unauthorized research. Since taking on a role with Kennedy in March to reevaluate the data, Geier regained access by visiting the CDC in Atlanta. He was given a laptop to remotely access the vaccine safety database. Currently, Geier is still limited to old data, and the ramifications of this cancelled meeting remain unclear. For more on this intriguing development, check out STAT’s report by Rose Broderick here.
Further Reading
-
Is your prenatal vitamin lacking a crucial component? The Cut
-
A Texas vaccine expert’s attempts to reach Kennedy: A story of challenges, KERA News
- First Opinion: Four reasons why generative AI chatbots may lead to psychosis among vulnerable groups, STAT
- Bipartisan effort underway to reinstate a national suicide hotline for LGBTQ+ youth, The 19th
- Understanding who will incur higher premiums if ACA enhanced subsidies are dropped, STAT
This rewritten content maintains the original HTML structure while creating a unique article for a WordPress platform, retaining essential details and links for reader engagement.
